Duration: CME/CE Points: Author(s):
CME : 0.5
MOC : 0.5

Matching Drugs to Genetic Abnormalities to Precisely Treat Cystic Fibrosis is organized by American Medical Association (AMA).

Recorded Date: Dec 05, 2017
End Date: Dec 05, 2020

Clinical Review Audio 26 min 07 sec

MOC/CME Information: 0.5 Credit CME

Cystic fibrosis is a common autosomal recessive disease. It is caused by any one of many discrete genetic abnormalities that affect chloride transport. Identification of specific genetic abnormalities enables clinicians to identify drugs that counteract the effects of the abnormal genes. In this podcast we review how genetic defects that cause cystic fibrosis are identified and how drugs that are likely to successfully treat the disease are matched to those genetic abnormalities.

Educational Objective:
•  To understand the pathogenesis of cystic fibrosis and its treatment.

Additional details will be posted as soon as information is available.

Target Audience

Gastroenterology, Plastic Surgery


Activity Fee : Fee Details will be updated soon


Gastroenterology, Plastic Surgery

Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.